Donnatal Drug Interactions
Currently displaying 45 drugs known to have a minor interaction with Donnatal (atropine / hyoscyamine / phenobarbital / scopolamine).
- 236 major drug interactions
- 573 moderate drug interactions
- 45 minor drug interactions
Minor interactions with Donnatal (atropine / hyoscyamine / phenobarbital / scopolamine)
Note: Showing generic names only.
A
B
C
D
E
F
G
I
L
M
N
O
P
R
S
T
Donnatal alcohol/food interactions
There are 6 alcohol/food interactions with Donnatal (atropine / hyoscyamine / phenobarbital / scopolamine).
Donnatal disease interactions
There are 34 disease interactions with Donnatal (atropine / hyoscyamine / phenobarbital / scopolamine) which include:
- autonomic neuropathy
- GI obstruction
- glaucoma
- obstructive uropathy
- reactive airway diseases
- myasthenia gravis
- infectious diarrhea
- acute alcohol intoxication
- drug dependence
- liver disease
- porphyria
- rash
- respiratory depression
- cardiovascular
- prolonged hypotension
- renal dysfunction
- cardiac disease
- tachycardia
- suicidal tendency
- coronary artery disease
- gastric ulcer
- gastroesophageal reflux
- ulcerative colitis
- liver disease
- renal failure
- adrenal insufficiency
- depression
- hematologic toxicity
- osteomalacia
- paradoxical reactions
- hypertension
- hyperthyroidism
- diarrhea
- fever
More about Donnatal (atropine / hyoscyamine / phenobarbital / scopolamine)
- Donnatal consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (53)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: anticholinergics/antispasmodics
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.